Use of Melatonin for Neuroprotection in Asphyxiated Newborns (MELPRO)
Use of Melatonin for Neuroprotection in Term Infants With Hypoxic-ischaemic Encephalopathy
Sponsor: AUSL Romagna Rimini
Listed as NCT03806816, this NA trial focuses on Asphyxia Perinatal and Cell Damage and remains ongoing. Sponsored by AUSL Romagna Rimini, it has been updated 9 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Unknown NA
-
Sep 2024 — Sep 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Feb 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Feb 2023 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Nov 2019 — Jan 2021 [monthly]
Recruiting NA
-
Apr 2019 — Nov 2019 [monthly]
Recruiting NA
-
Mar 2019 — Apr 2019 [monthly]
Recruiting NA
-
Feb 2019 — Mar 2019 [monthly]
Recruiting NA
First recorded
Dec 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AUSL Romagna Rimini
- University Hospital of Ferrara
For direct contact, visit the study record on ClinicalTrials.gov .